Parma, Italy

Marco Farina

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marco Farina. Retrieved from https://idiyas.com/inventor/marco-farina-clb0womr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marco Farina: Innovator in Medicinal Chemistry

Introduction

Marco Farina is a distinguished inventor based in Parma, Italy. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on glycine derivatives.

Latest Patents

Marco Farina holds a patent for "Glycine derivatives and medicinal compositions thereof." This patent focuses on alkaloid aminoester derivatives that act as muscarinic receptor antagonists, showcasing his expertise in developing new medicinal compounds.

Career Highlights

Farina is currently employed at Chiesi Farmaceutici S.p.a., a prominent pharmaceutical company known for its commitment to research and development in healthcare. His work at Chiesi has allowed him to explore various avenues in medicinal chemistry and contribute to the advancement of therapeutic solutions.

Collaborations

Throughout his career, Marco has collaborated with notable colleagues, including Mauro Riccaboni and Gabriele Amari. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

Marco Farina's contributions to medicinal chemistry, particularly through his patent on glycine derivatives, highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…